Works matching Angiogenesis inhibitors

Results: 2596

Endogenous angiogenesis inhibitors.

Published in:

APMIS, 2004, v. 112, n. 7/8, p. 496, doi. 10.1111/j.1600-0463.2004.apm11207-0809.x

By:

Folkman, Judah

Publication type:

Article

The efficacy, safety, and beneficiary population of angiogenesis inhibitor apatinib plus chemotherapy in recurrent platinum‐resistant ovarian cancer patients: A comparative cohort study.

Published in:

Journal of Obstetrics & Gynaecology Research, 2024, v. 50, n. 8, p. 1345, doi. 10.1111/jog.15976

By:

Wu, Chunyan;
Yan, Jiali;
Wu, Yun

Publication type:

Article

A novel four-step system for screening angiogenesis inhibitors.

Published in:

Molecular Medicine Reports, 2013, v. 8, n. 6, p. 1734, doi. 10.3892/mmr.2013.1704

By:

QIN ZHOU;
CUI-LING QI;
YAN LI;
XIAO-DONG HE;
JIANG-CHAO LI;
QIAN-QIAN ZHANG;
LAN TIAN;
MING ZHANG;
ZHE HAN;
HUIPING WANG;
XUESONG YANG;
LI-JING WANG

Publication type:

Article

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221082339

By:

Yang, Guangjian;
Yang, Yaning;
Liu, Runze;
Li, Weihua;
Xu, Haiyan;
Hao, Xuezhi;
Li, Junling;
Xing, Puyuan;
Zhang, Shuyang;
Ai, Xin;
Xu, Fei;
Wang, Yan

Publication type:

Article

Efficacy and safety of EGFR-TKIs in combination with angiogenesis inhibitors as first-line therapy for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and meta-analysis.

Published in:

BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02472-x

By:

Hu, Di;
Zhou, Yan-Yan;
Ma, Hong-Bo;
Tao, Miao-Miao;
Huang, Qun-Zhen;
Yang, Zhen-Zhou;
Zhou, Qi

Publication type:

Article

The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer.

Published in:

Cancer Medicine, 2019, v. 8, n. 13, p. 5930, doi. 10.1002/cam4.2462

By:

Shi, Xiaoshun;
Dong, Xiaoying;
Young, Sylvia;
Chen, Allen Menglin;
Liu, Xiguang;
Zheng, Zhouxia;
Huang, Kailing;
Lu, Di;
Feng, Siyang;
Morahan, Grant;
Cai, Kaican

Publication type:

Article

Clinical efficacy and safety of angiogenesis inhibitors: sex differences and current challenges.

Published in:

Cardiovascular Research, 2022, v. 118, n. 4, p. 988, doi. 10.1093/cvr/cvab096

By:

Cignarella, Andrea;
Fadini, Gian Paolo;
Bolego, Chiara;
Trevisi, Lucia;
Boscaro, Carlotta;
Sanga, Viola;
Seccia, Teresa Maria;
Rosato, Antonio;
Rossi, Gian Paolo;
Barton, Matthias

Publication type:

Article

Study of siRNA Delivery via Polymeric Nanoparticles in Combination with Angiogenesis Inhibitor for The Treatment of AFP -Related Liver Cancer.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12666, doi. 10.3390/ijms232012666

By:

Punuch, Kittiporn;
Wongwan, Chamaiphorn;
Jantana, Saranrat;
Somboonyosdech, Chayapol;
Rodponthukwaji, Kamonlatth;
Kunwong, Natsuda;
Nguyen, Kytai T.;
Sirivatanauksorn, Vorapan;
Sirivatanauksorn, Yongyut;
Srisawat, Chatchawan;
Punnakitikashem, Primana

Publication type:

Article

Angiogenesis inhibitors effects on overall survival and progression-free survival in newly diagnosed primary glioblastoma multiforme: a meta-analysis of twelve randomized clinical trials.

Published in:

2025

By:

Motamed-Sanaye, Ali;
Mortezaei, Ali;
Afshari, Amir R.;
Saadatian, Zahra;
Faraji, Amir H.;
Sheehan, Jason P.;
Mokhtari, Ali Mohammad

Publication type:

Literature Review

Anti-Tumor Effect of Angiogenesis Inhibitor TNP-470 on the Human Nasopharyngeal Carcinoma Cell Line NPC/HK1.

Published in:

Oncology, 1999, v. 57, n. 1, p. 36, doi. 10.1159/000011998

By:

Qian, Chao-Nan;
Min, Hua-Qing;
Lin, Han-Liang;
Feng, Gong-Kan;
Ye, Yan-Li;
Wang, Lian-Gui;
Kuang, Zhu-Ji

Publication type:

Article

Effect of retinoic acid on renal development in newborn mice treated with an angiogenesis inhibitor.

Published in:

Pediatrics International, 2010, v. 52, n. 3, p. 386, doi. 10.1111/j.1442-200X.2009.02959.x

By:

Soo Jeong Lee;
Su Jin Cho;
Sun Young Ju;
Kyung-Ha Ryu;
Soon Hee Sung;
Eun Ae Park

Publication type:

Article

Review: Angiogenesis inhibitors in the treatment of non-small cell lung cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 2, p. 95, doi. 10.1177/1758834009338633

By:

Lind, Joline S.W.;
Smit, Egbert F.

Publication type:

Article

A MgAl-LDH-CuS nanosheet-based thermo-responsive composite hydrogel with nir-responsive angiogenesis inhibitor releasing capability for multimode starvation therapy.

Published in:

Journal of Nanobiotechnology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12951-024-02384-w

By:

Liu, Xueyan;
Hu, Tingting;
Jia, Yijiang;
Yang, Shuqing;
Yang, Yu;
Cui, Zhuolin;
Wang, Tao;
Liang, Ruizheng;
Tan, Chaoliang;
Wang, Yuji

Publication type:

Article

Risk of HBV reactivation in HCC patients undergoing combination therapy of PD-1 inhibitors and angiogenesis inhibitors in the antiviral era.

Published in:

Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 3, p. 1, doi. 10.1007/s00432-024-05677-7

By:

Wang, Rui;
Tan, Guili;
Lei, Dingjia;
Li, Yadi;
Gong, JiaoJiao;
Tang, Yao;
Pang, Hao;
Luo, Huating;
Qin, Bo

Publication type:

Article

The efficacy and toxicity of angiogenesis inhibitors for ovarian cancer: a meta-analysis of randomized controlled trials.

Published in:

Archives of Gynecology & Obstetrics, 2021, v. 303, n. 2, p. 285, doi. 10.1007/s00404-020-05865-z

By:

Guo, Chongzhen;
Yan, Chengda;
Qu, Lianyue;
Du, Rongrong;
Lin, Jianyang

Publication type:

Article

Brain-specific angiogenesis inhibitor 2 regulates VEGF through GABP that acts as a transcriptional repressor

Published in:

FEBS Letters, 2006, v. 580, n. 2, p. 669, doi. 10.1016/j.febslet.2005.12.086

By:

Jeong, Byung Chul;
Kim, Mi-Young;
Lee, Ji Hee;
Kee, Hae Jin;
Kho, Dhong Hyo;
Han, Kae Eun;
Qian, Yong Ri;
Kim, Jong-Keun;
Kim, Kyung Keun

Publication type:

Article

Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma

Published in:

FEBS Letters, 2004, v. 569, n. 1-3, p. 307, doi. 10.1016/j.febslet.2004.06.011

By:

Kee, Hae Jin;
Ahn, Kyu Youn;
Choi, Ki Choon;
Won Song, Jung;
Heo, Tag;
Jung, Shin;
Kim, Jong-Keun;
Bae, Choon Sang;
Kim, Kyung Keun

Publication type:

Article

Antiangiogéniques et métastases cérébrales: plus de peur que de mal ?

Published in:

Oncologie (Tech Science Press), 2012, v. 14, n. 4, p. 230, doi. 10.1007/s10269-012-2144-y

By:

Hadoux, J.;
Besse, B.

Publication type:

Article

First‐line immunotherapy or angiogenesis inhibitor combined with chemotherapy for advanced non‐small cell lung cancer with EGFR exon 20 insertions: Real‐world evidence from China.

Published in:

Cancer Medicine, 2023, v. 12, n. 1, p. 335, doi. 10.1002/cam4.4852

By:

Yang, Guangjian;
Yang, Yaning;
Liu, Runze;
Li, Weihua;
Xu, Haiyan;
Hao, Xuezhi;
Li, Junling;
Zhang, Shuyang;
Xu, Fei;
Lei, Siyu;
Wang, Yan

Publication type:

Article

Case report: Pathological complete response to perioperative treatment of radiotherapy combined with angiogenesis inhibitor in a patient with pleomorphic liposarcoma.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.925233

By:

Chenlu Zhang;
Wenshuai Liu;
Binliang Wang;
Na Zhu;
Xi Guo;
Zhiming Wang;
Rongyuan Zhuang;
Yang You;
Yong Zhang;
Hanxing Tong;
Weiqi Lu;
Yuhong Zhou

Publication type:

Article

Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro- and nanoparticles.

Published in:

Journal of Microencapsulation, 2010, v. 27, n. 1, p. 57, doi. 10.3109/02652040902954729

By:

d'Angelo, Ivana;
Parajó, Yolanda;
Horváth, Anikó;
Kéri, György;
La Rotonda, Maria Immacolata;
Alonso, María José

Publication type:

Article

Endostatin, an Inhibitor of Angiogenesis, Decreases After Bidirectional Superior Cavopulmonary Anastamosis.

Published in:

Pediatric Cardiology, 2013, v. 34, n. 2, p. 291, doi. 10.1007/s00246-012-0441-2

By:

Field-Ridley, Aida;
Heljasvaara, Ritva;
Pihlajaniemi, Taina;
Adatia, Ian;
Sun, Christine;
Keller, Roberta;
Gong, Wen;
Datar, Sanjeev;
Oishi, Peter;
Fineman, Jeffrey

Publication type:

Article

Current Status of Angiogenesis Inhibitors as Second-Line Treatment for Unresectable Colorectal Cancer.

Published in:

Cancers, 2023, v. 15, n. 18, p. 4564, doi. 10.3390/cancers15184564

By:

Otsu, Satoshi;
Hironaka, Shuichi

Publication type:

Article

Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy.

Published in:

Cancers, 2021, v. 13, n. 14, p. 3562, doi. 10.3390/cancers13143562

By:

Nair, Mitra;
Bolyard, Chelsea;
Lee, Tae Jin;
Kaur, Balveen;
Yoo, Ji Young

Publication type:

Article

Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis.

Published in:

Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251348310

By:

Zhou, Linjing;
Li, Yuwei;
Wang, Le;
Chen, Kaiyan;
Zhou, Shichao;
Chen, Yunfei;
Sun, Jing;
Tong, Yunfeng;
Fan, Yun

Publication type:

Article

Isolation and bioactivity of an angiogenesis inhibitor extracted from the cartilage of Dasyatis akajei.

Published in:

Asia Pacific Journal of Clinical Nutrition, 2007, v. 16, p. 286

By:

Hongyu Luo;
Jiangjing Xu;
Xinwei Yu

Publication type:

Article

程序性死亡受体 1 / 程序性死亡受体配体 1 抑制剂联合抗血管生成药物治疗晚期肝细胞癌的临床研究进展.

Published in:

Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2024, n. 1, p. 124, doi. 10.14009/j.issn.1672-2124.2024.01.027

By:

江雪;
葛晓英;
郑丹;
鲍蕾蕾

Publication type:

Article

Efficacy and safety of different angiogenesis inhibitors combined with PARP inhibitors in the treatment of ovarian cancer: A systematic review and meta‑analysis.

Published in:

Oncology Letters, 2025, v. 29, n. 1, p. N.PAG, doi. 10.3892/ol.2024.14782

By:

Huang, Xuemei;
Luo, Jianxiu;
Gu, Liqin

Publication type:

Article

Angiogenesis Inhibitors: New Agents in Cancer Therapy.

Published in:

Drugs & Aging, 2000, v. 17, n. 4, p. 249, doi. 10.2165/00002512-200017040-00001

By:

Ryan, C.J.;
Wilding, G.

Publication type:

Article

The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis.

Published in:

Journal of Ovarian Research, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13048-022-01028-7

By:

Zhang, Chunmei;
Zhao, Wancheng

Publication type:

Article

血管生成抑制剂治疗恶性胸膜间皮瘤的有效性及安全性的 Meta 分析.

Published in:

Practical Pharmacy & Clinical Remedies, 2022, v. 25, n. 2, p. 128, doi. 10.14053/j.cnki.ppcr.202202003

By:

李晶;
张彩苹

Publication type:

Article

Cardiovascular toxicity profiles of immune checkpoint inhibitors with or without angiogenesis inhibitors: a real-world pharmacovigilance analysis based on the FAERS database from 2014 to 2022.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1127128

By:

Yanfeng Wang;
Chanjuan Cui;
Lei Deng;
Lin Wang;
Xiayang Ren

Publication type:

Article

Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution.

Published in:

EMBO Journal, 1998, v. 17, n. 6, p. 1656, doi. 10.1093/emboj/17.6.1656

By:

Hohenester, Erhard;
Sasaki, Takako;
Olsen, Björn R.;
Timpl, Rupert

Publication type:

Article

DMPPQA, a novel angiogenesis inhibitor, induces apoptosis in human colon cancer HCT-116 cells and HUVECs.

Published in:

Cell Biology International, 2014, v. 38, n. 3, p. 343, doi. 10.1002/cbin.10209

By:

Ren, Jie;
Jiang, Hefei;
Zhao, Juan;
Xin, Wenqun;
Xu, Yuanyuan;
Chen, Xin;
Hu, Kun

Publication type:

Article

Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinics.

Published in:

Medical Oncology, 2012, v. 29, n. 2, p. 786, doi. 10.1007/s12032-011-9922-z

By:

Feinberg, Bruce;
Jolly, Pradeep;
Wang, Si-Tien;
Fortner, Barry;
Scott, Jeffrey;
Gilmore, James;
Neary, Maureen;
Duh, Mei

Publication type:

Article

Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature.

Published in:

Current Oncology, 2021, v. 28, n. 1, p. 661, doi. 10.3390/curroncol28010064

By:

Kasherman, Lawrence;
Doi, jeffrey;
Karakasis, Katherine;
Schiff, Jeffrey;
Kitchlu, Abhijat;
Lheureux, Stephanie;
Oza, Amit M.

Publication type:

Article

A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 3, p. 295, doi. 10.1007/s00280-004-0871-5

By:

Cooney, Matthew;
Tserng, Kou-Yi;
Makar, Vinit;
McPeak, R.;
Ingalls, Stephen;
Dowlati, Afshin;
Overmoyer, Beth;
McCrae, Keith;
Ksenich, Pamela;
Lavertu, Pierre;
Ivy, Percy;
Hoppel, Charles;
Remick, Scot

Publication type:

Article

Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors.

Published in:

2004

By:

Tran, Hai T.;
Blumenschein Jr., George R.;
Charles Lu;
Meyers, Christina A.;
Papadimitrakopoulou, Vali;
Fossella, Frank V.;
Zinner, Ralph;
Madden, Timothy;
Smythe, Lori G.;
Puduvalli, Vinay K.;
Munden, Reggie;
Truong, Mylene;
Herbst, Roy S.;
Blumenschein, George R Jr;
Lu, Charles

Publication type:

journal article

Efficacy and safety of angiogenesis inhibitors combined with poly ADP ribose polymerase inhibitors in the maintenance treatment of advanced ovarian cancer: a meta-analysis.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1477105

By:

Huang, Renming;
Ji, Feng;
Huang, Leyi;
Qin, Yueying;
Liang, Zhiyu;
Huang, Miaoyan;
Li, Chunyan;
Ban, Jian

Publication type:

Article

Localization of the Angiogenesis Inhibitor Thrombospondin in Human Synovial Tissues.

Published in:

Pathobiology, 1993, v. 61, n. 1, p. 1, doi. 10.1159/000163752

By:

Koch, Alisa E.;
Friedman, Jon;
Burrows, James C.;
Haines, George K.;
Bouck, Noel P.

Publication type:

Article

Angiogenesis Inhibitor Drug-induced Benign Migratory Glossitis in a Patient of Juvenile-onset Recurrent Respiratory Papillomatosis under Maintenance Therapy.

Published in:

International Journal of Clinical Pediatric Dentistry, 2024, v. 17, n. 1, p. 92, doi. 10.5005/jp-journals-10005-2739

By:

Kalra, Namita;
Tyagi, Rishi;
Khatri, Amit;
Kulood, Khadeeja;
Sabherwal, Puja

Publication type:

Article

The promoter of brain-specific angiogenesis inhibitor 1-associated protein 4 drives developmentally targeted transgene expression mainly in adult cerebral cortex and hippocampus

Published in:

FEBS Letters, 2004, v. 566, n. 1-3, p. 87, doi. 10.1016/j.febslet.2004.03.106

By:

Kim, Mi-Young;
Ahn, Kyu Youn;
Lee, Seon Min;
Koh, Jeong Tae;
Chun, Byeong Jo;
Bae, Choon Sang;
Lee, Kee Sook;
Kim, Kyung Keun

Publication type:

Article

Gold nanocrystals as potential inhibitors of tumor angiogenesis: implications in diagnosis and drug delivery.

Published in:

Journal of Nanoparticle Research, 2021, v. 23, n. 7, p. 1, doi. 10.1007/s11051-021-05276-4

By:

Rani, Vinitha;
Venkatesan, Jayachandran;
Prabhu, Ashwini

Publication type:

Article

Toxicité cutanée induite par les thérapies ciblées anti-angiogéniques.

Published in:

Oncologie (Tech Science Press), 2009, v. 11, n. 5, p. 291, doi. 10.1007/s10269-009-1068-7

By:

Sibaud, V.

Publication type:

Article

Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non‐small cell lung cancer harboring EGFR mutation.

Published in:

Cancer Medicine, 2021, v. 10, n. 21, p. 7503, doi. 10.1002/cam4.4268

By:

Kodama, Hiroaki;
Kenmotsu, Hirotsugu;
Kawabata, Takanori;
Notsu, Akifumi;
Yabe, Michitoshi;
Nishioka, Naoya;
Miyawaki, Eriko;
Miyawaki, Taichi;
Mamesaya, Nobuaki;
Kobayashi, Haruki;
Omori, Shota;
Wakuda, Kazushige;
Ono, Akira;
Naito, Tateaki;
Murakami, Haruyasu;
Takahashi, Toshiaki

Publication type:

Article

Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1527570

By:

Yang, Yuhui;
Long, Pingping;
Tuo, Ying;
Wang, Xiaoxiao

Publication type:

Article

Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials.

Published in:

OncoTargets & Therapy, 2015, v. 8, p. 2775, doi. 10.2147/OTT.S88102

By:

Lingdi Zhao;
Wei Li;
Huiying Zhang;
Nan Hou;
Lanwei Guo;
Quanli Gao

Publication type:

Article

Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents.

Published in:

Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00259

By:

Cesca, Marta;
Bizzaro, Francesca;
Zucchetti, Massimo;
Giavazzi, Raffaella

Publication type:

Article

Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future.

Published in:

Cancers, 2022, v. 14, n. 6, p. 1406, doi. 10.3390/cancers14061406

By:

Kasherman, Lawrence;
Siu, Derrick Ho Wai;
Woodford, Rachel;
Harris, Carole A.

Publication type:

Article

Tumor Angiogenesis Inhibitors.

Published in:

Biochemistry (00062979), 2003, v. 68, n. 5, p. 497, doi. 10.1023/A:1023984107503

By:

Kiselev, S. M.;
Lutsenko, S. V.;
Severin, S. E.;
Severin, E. S.

Publication type:

Article